Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Giovanni Barosi
JAK Inhibition With Ruxolitinib Versus Best Available Therapy for Myelofibrosis
New England Journal of Medicine
Medicine
Addressing and Proposing Solutions for Unmet Clinical Needs in the Management of Myeloproliferative Neoplasm-Associated Thrombosis: A Consensus-Based Position Paper
Blood Cancer Journal
Oncology
Hematology
Role of TGF-β1/miR-382-5p/SOD2 Axis in the Induction of Oxidative Stress in CD34+ Cells From Primary Myelofibrosis
Molecular Oncology
Cancer Research
Medicine
Oncology
Genetics
Molecular Medicine
Critical Appraisal of the Role of Ruxolitinib in Myeloproliferative Neoplasm-Associated Myelofibrosis
OncoTargets and Therapy
Oncology
Pharmacology
Activation of Non-Canonical TGF-β1 Signaling Indicates an Autoimmune Mechanism for Bone Marrow Fibrosis in Primary Myelofibrosis
Blood Cells, Molecules, and Diseases
Molecular Medicine
Hematology
Molecular Biology
Cell Biology
Circulating CD34+, CD133+, and Vascular Endothelial Growth Factor Receptor 2–Positive Endothelial Progenitor Cells in Myelofibrosis With Myeloid Metaplasia
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
The Constitutive Mobilization of Bone Marrow-Repopulating Cells Into the Peripheral Blood in Idiopathic Myelofibrosis
Blood
Biochemistry
Immunology
Cell Biology
Hematology